Global Prenatal Screening Tests Devices Market Overview:
Global Prenatal Screening Tests Devices Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2026-2035, Considering the Base Year As 2025.
Global Prenatal Screening Tests Devices Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Prenatal Screening Tests Devices involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Prenatal Screening Tests Devices Market:
The Prenatal Screening Tests Devices Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Prenatal Screening Tests Devices Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Prenatal Screening Tests Devices Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Prenatal Screening Tests Devices market has been segmented into:
Alpha-Fetoprotein (AFP
By Application, Prenatal Screening Tests Devices market has been segmented into:
hCG
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Prenatal Screening Tests Devices market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Prenatal Screening Tests Devices market.
Top Key Players Covered in Prenatal Screening Tests Devices market are:
Illumina Inc
BGI Genomics Co Ltd
Yourgene Health Plc
Eurofins Scientific SE
Agilent Technologies Inc
Roche Diagnostics International Ltd
PerkinElmer Inc
Beckman Coulter Inc
Abbott Laboratories
Siemens Healthineers AG
Quidel Corp
Thermo Fisher Scientific Inc
Tosoh Corp
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Prenatal Screening Tests Devices Market Type
4.1 Prenatal Screening Tests Devices Market Snapshot and Growth Engine
4.2 Prenatal Screening Tests Devices Market Overview
4.3 Alpha-Fetoprotein (AFP
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Alpha-Fetoprotein (AFP: Geographic Segmentation Analysis
Chapter 5: Prenatal Screening Tests Devices Market Application
5.1 Prenatal Screening Tests Devices Market Snapshot and Growth Engine
5.2 Prenatal Screening Tests Devices Market Overview
5.3 hCG
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 hCG: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Prenatal Screening Tests Devices Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 ILLUMINA INC
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 BGI GENOMICS CO LTD
6.4 YOURGENE HEALTH PLC
6.5 EUROFINS SCIENTIFIC SE
6.6 AGILENT TECHNOLOGIES INC
6.7 ROCHE DIAGNOSTICS INTERNATIONAL LTD
6.8 PERKINELMER INC
6.9 BECKMAN COULTER INC
6.10 ABBOTT LABORATORIES
6.11 SIEMENS HEALTHINEERS AG
6.12 QUIDEL CORP
6.13 THERMO FISHER SCIENTIFIC INC
6.14 TOSOH CORP
Chapter 7: Global Prenatal Screening Tests Devices Market By Region
7.1 Overview
7.2. North America Prenatal Screening Tests Devices Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Alpha-Fetoprotein (AFP
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 hCG
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Prenatal Screening Tests Devices Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Alpha-Fetoprotein (AFP
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 hCG
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Prenatal Screening Tests Devices Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Alpha-Fetoprotein (AFP
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 hCG
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Prenatal Screening Tests Devices Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Alpha-Fetoprotein (AFP
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 hCG
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Prenatal Screening Tests Devices Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Alpha-Fetoprotein (AFP
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 hCG
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Prenatal Screening Tests Devices Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Alpha-Fetoprotein (AFP
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 hCG
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Prenatal Screening Tests Devices Scope:
|
Report Data
|
Prenatal Screening Tests Devices Market
|
|
Prenatal Screening Tests Devices Market Size in 2025
|
USD XX million
|
|
Prenatal Screening Tests Devices CAGR 2025 - 2032
|
XX%
|
|
Prenatal Screening Tests Devices Base Year
|
2024
|
|
Prenatal Screening Tests Devices Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Illumina Inc, BGI Genomics Co Ltd, Yourgene Health Plc, Eurofins Scientific SE, Agilent Technologies Inc, Roche Diagnostics International Ltd, PerkinElmer Inc, Beckman Coulter Inc, Abbott Laboratories, Siemens Healthineers AG, Quidel Corp, Thermo Fisher Scientific Inc, Tosoh Corp.
|
|
Key Segments
|
By Type
Alpha-Fetoprotein (AFP
By Applications
hCG
|